Literature DB >> 24298358

Clinical response of 277 patients with spinal cord injury to stem cell therapy in iraq.

Abdulmajeed Alwan Hammadi1, Andolina Marino, Saad Farhan.   

Abstract

BACKGROUND AND OBJECTIVES: Spinal cord injury is a common neurological problem secondary to car accidents, war injuries and other causes, it may lead to varying degrees of neurological disablement, and apart from physiotherapy there is no available treatment to regain neurological function loss. Our aim is to find a new method using autologous hematopoietic stem cells to gain some of the neurologic functions lost after spinal cord injury. METHODS AND
RESULTS: 277 patients suffering from spinal cord injury were submitted to an intrathecally treatment with peripheral stem cells. The cells were harvested from the peripheral blood after a treatment with G-CSF and then concentrated to 4∼ 6 ml. 43% of the patients improved; ASIA score shifted from A to B in 88 and from A to C in 32. The best results were achieved in patients treated within one year from the injury.
CONCLUSIONS: Since mesenchymal cells increase in the peripheral blood after G-CSF stimulation, a peripheral blood harvest seems easier and cheaper than mesenchymal cell cultivation prior to injection. It seems reasonable treatment for spinal cord injury.

Entities:  

Keywords:  Mesenchymal cells; Spine injury; Stem cells

Year:  2012        PMID: 24298358      PMCID: PMC3840983          DOI: 10.15283/ijsc.2012.5.1.76

Source DB:  PubMed          Journal:  Int J Stem Cells        ISSN: 2005-3606            Impact factor:   2.500


  9 in total

1.  Recruitment of bone-marrow-derived cells by skeletal and cardiac muscle in adult dystrophic mdx mice.

Authors:  R E Bittner; C Schöfer; K Weipoltshammer; S Ivanova; B Streubel; E Hauser; M Freilinger; H Höger; A Elbe-Bürger; F Wachtler
Journal:  Anat Embryol (Berl)       Date:  1999-05

2.  Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: a pilot study.

Authors:  Bassem Yamout; Roula Hourani; Haytham Salti; Wissam Barada; Taghrid El-Hajj; Aghiad Al-Kutoubi; Aline Herlopian; Elizabeth Kfoury Baz; Rami Mahfouz; Rima Khalil-Hamdan; Nabeela M A Kreidieh; Marwan El-Sabban; Ali Bazarbachi
Journal:  J Neuroimmunol       Date:  2010-08-21       Impact factor: 3.478

3.  Transplantation of human marrow stromal cells and mono-nuclear bone marrow cells into the injured spinal cord: a comparative study.

Authors:  Amer F Samdani; Courtney Paul; Randal R Betz; Itzhak Fischer; Birgit Neuhuber
Journal:  Spine (Phila Pa 1976)       Date:  2009-11-15       Impact factor: 3.468

4.  Granulocyte-colony stimulating factor-mobilized mesenchymal stem cells: A new resource for rapid engraftment in hematopoietic stem cell transplantation.

Authors:  Cheng Zhang; Xi Zhang; Xing-Hua Chen
Journal:  Med Hypotheses       Date:  2010-11-02       Impact factor: 1.538

5.  Direct intrathecal implantation of mesenchymal stromal cells leads to enhanced neuroprotection via an NFkappaB-mediated increase in interleukin-6 production.

Authors:  Peter A Walker; Matthew T Harting; Fernando Jimenez; Shinil K Shah; Shibani Pati; Pramod K Dash; Charles S Cox
Journal:  Stem Cells Dev       Date:  2010-06       Impact factor: 3.272

6.  Clinical outcome of 50 progressive multiple sclerosis patients treated with cellular therapy in iraq.

Authors:  Abdul Majeed A Hammadi; Andolina Marino; Saad Farhan
Journal:  Int J Stem Cells       Date:  2011-11       Impact factor: 2.500

7.  Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study.

Authors:  Katarina Le Blanc; Francesco Frassoni; Lynne Ball; Franco Locatelli; Helene Roelofs; Ian Lewis; Edoardo Lanino; Berit Sundberg; Maria Ester Bernardo; Mats Remberger; Giorgio Dini; R Maarten Egeler; Andrea Bacigalupo; Willem Fibbe; Olle Ringdén
Journal:  Lancet       Date:  2008-05-10       Impact factor: 79.321

8.  Purification and characterization of mouse hematopoietic stem cells.

Authors:  G J Spangrude; S Heimfeld; I L Weissman
Journal:  Science       Date:  1988-07-01       Impact factor: 47.728

9.  Bone marrow-derived mesenchymal stem cell therapy as a candidate disease-modifying strategy in Parkinson's disease and multiple system atrophy.

Authors:  Phil Hyu Lee; Hyun Jung Park
Journal:  J Clin Neurol       Date:  2009-03-31       Impact factor: 3.077

  9 in total
  3 in total

Review 1.  Recent Advances in Cell and Functional Biomaterial Treatment for Spinal Cord Injury.

Authors:  Tianyi Liu; Wenhao Zhu; Xiaoyu Zhang; Chuan He; Xiaolong Liu; Qiang Xin; Kexin Chen; Haifeng Wang
Journal:  Biomed Res Int       Date:  2022-08-08       Impact factor: 3.246

2.  Clinical translation of stem cell therapy for spinal cord injury still premature: results from a single-arm meta-analysis based on 62 clinical trials.

Authors:  Zhizhong Shang; Mingchuan Wang; Baolin Zhang; Xin Wang; Pingping Wanyan
Journal:  BMC Med       Date:  2022-09-05       Impact factor: 11.150

Review 3.  PubMed-indexed neurosurgical research productivity of Iraq-based neurosurgeons.

Authors:  Samer S Hoz; Zahraa F Al-Sharshahi; Ignatius N Esene; Ali A Dolachee; Ali M Neamah; Aktham O Al-Khafaji; Mohammed A Al-Dhahir; Hatem Sadik
Journal:  Surg Neurol Int       Date:  2021-05-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.